
Tylenol, Theraflu, NyQuil, and DayQuil
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Wilson et al. v. Johnson & Johnson Consumer, Inc. et al.
23-cv-21276, D.N.J.
(Oct. 2023)
Children’s Dimetapp, DayQuil, Mucinex, Mucinex Children’s, and Sudafed
Falsely marketing that phenylephrine products treat nasal congestion when phenylephrine is not an effective decongestant when taken orally
Pending
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines are decongestants
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Misleadingly marketing drink mixes using the phrase “Natural fruit flavor” and images of raspberries when they contain artificial flavoring ingredients
Allegations: Misleadingly marketing products as if they treat symptoms of coughs and colds
Allegations: False natural claims
Allegations: False natural claims
These brand-relationship disclosures are far from world-class.
Instant replay shows six instances in which Super Bowl 52 advertisers have fumbled ad claims.
Ad Watchdog TINA.org Files FTC Complaint MADISON, CONN. January 23, 2018 – Despite a national advertising campaign showcasing patriotic imagery, highlighting its Boston headquarters, and heavily promoting its “Made in…
TINA.org files FTC complaint over Gillette’s false and deceptive Made in the USA claims.
The U.S. flag features prominently in this Gillette ad despite the fact that many of its products aren’t “Made in the USA.”